Organiser: The Alan Turing Institute

The Turing-Roche strategic partnership is a collaboration in advanced analytics between Roche and the Turing, focused on enabling the transformative benefits of personalised healthcare to become a reality for patients around the world. The Turing-Roche knowledge share series brings together members of Roche and Turing's networks to showcase partnership research and share knowledge. 

The November knowledge share will explore the topic of AI in Clinical Trials. The event speakers are Nandini Chitale and Michael DAndrea, Data Scientists at Roche (Genentech) and Louise Coutts, Senior Research Associate at the Alan Turing Institute.

Nandini and Michael will discuss recent work on evaluating machine learning for forecasting key clinical trial operational metrics. They will share how data-driven forecasts based on trial features such as procedures, eligibility criteria, and endpoints can be potentially useful for trial design and planning, which in turn can improve key outcomes related to patient recruitment and trial duration.

Louise will discuss the collaboration between the Turing and the MRC Clinical Trials Unit, where they are exploring the impact of statistical machine learning on the design, conduct and analysis of randomised clinical trials.

This is an online event aimed at a technical audience. For further details and to register, please visit: The Turing-Roche knowledge share series: AI in clinical trials | The Alan Turing Institute.